What is the CVR number of Betamab ApS?

Betamab ApS is registered with CVR / Virk under CVR 40337326.

What is the revenue of Betamab ApS?

Betamab ApS reported revenue of DKK -736K in 2020.

How many employees does Betamab ApS have?

Betamab ApS employs 2 people as of the latest annual report.

Who is the CEO of Betamab ApS?

Preben Meldgaard is Unofficial title of Betamab ApS, in role since 2021.

Who is the chairman of Betamab ApS?

Teit Eliot Johansen chairs the board of Betamab ApS, in role since 2020.

Where is Betamab ApS headquartered?

Betamab ApS's registered address is Hørsholmvej 11.

Betamab ApS

APSIn liquidation

CVR 40337326Hørsholmvej 11Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 20192 employees

Full Risika report

Revenue 2020

DKK -736K

+114% vs 2019

EBITDA margin

236.9%

-408% vs 2019

Equity ratio

56.5%

Financial strength

Net profit 2020

DKK -1,4M

-408% vs 2019

EBITDA — year on yearDKK millions

Key figuresAnnual report 2020

Revenue	DKK -736K	+114%
EBITDA	DKK -1,7M	-408%
Net profit	DKK -1,4M	-408%
Total assets	DKK 741K	+252%
Equity	DKK 419K	+293%
Employees	2	—

Item	2019	2020
Revenue	-343	-736
Staff expenses	-0	-1.008
EBITDA	-343	-1.744
Depreciation & amort.	-0	-0
EBIT	-343	-1.744
Net financials	-1	-4
Profit before tax	-344	-1.748
Tax	-76	-385
Net profit	-268	-1.364

Item	2019	2020
Total assets	211	741
Equity	-217	419
Long-term debt	0	11
Short-term debt	428	312
Total debt	428	322

Name	Role	Member since	Age	Other directorships
PM Preben Meldgaard Unofficial title	Unofficial title	2021	—	—

Name	Role	Member since	Age	Other directorships
TE Teit Eliot Johansen	Chairman	2020	—	—

Shareholder	Type	Ownership	Votes	Since
Morten Peter Meldal	Individual	33.3%	33.3%	2020
Jan Albert Nikolaisen	Individual	10.0%	10.0%	2019
ALK-ABELLÓ A/S	Company	5.0%	5.0%	2020
Søren Mouritsen	Individual	33.3%	33.3%	2020
Jan Nikolaisen	Individual	10.0%	10.0%	2019

Person	Role here	Other companies
Preben Meldgaard	Unofficial title	0 companies
Teit Eliot Johansen	Chairman	0 companies

Betamab ApS

APSIn liquidation

CVR 40337326Hørsholmvej 11Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 20192 employees

Full Risika report

Revenue 2020

DKK -736K

+114% vs 2019

EBITDA margin

236.9%

-408% vs 2019

Equity ratio

56.5%

Financial strength

Net profit 2020

DKK -1,4M

-408% vs 2019

EBITDA — year on yearDKK millions

Key figuresAnnual report 2020

Revenue	DKK -736K	+114%
EBITDA	DKK -1,7M	-408%
Net profit	DKK -1,4M	-408%
Total assets	DKK 741K	+252%
Equity	DKK 419K	+293%
Employees	2	—